Abstract
Abstract
Purpose
Adverse drug reactions (ADRs) contribute significantly to healthcare burden. However, they are largely preventable through appropriate management processes. This narrative review aims to identify the quality indicators that should be considered for routine monitoring of processes within hospital ADR management systems. It also examines the potential reasons behind variation in ADR management practices amongst HCPs, and explores possible solutions, focusing on targeted education programmes, to improve both the quality and quantity indicators of ADR management processes.
Methods
A comprehensive literature review was conducted to explore relevant themes and topics concerning ADR management, quality indicators and educational interventions.
Results
Substantial variability exists in ADR management amongst healthcare professionals (HCPs) with regard to reporting rates, characteristics of ADRs reported, quality of assessment, completeness of reports and, most importantly, risk communication practices. These variable practices not only threaten patient safety but also undermine pharmacovigilance processes. To date, quality indicators to monitor ADR management practices within hospital settings remain ill-defined. Furthermore, evidence behind effective interventions, especially in the form of targeted education strategies, to improve the quality of ADR management remains limited.
Conclusions
The focus of ADR management in hospitals should be to promote patient safety through comprehensive assessment, risk communication and safe prescribing. There is a need to develop a system to define, measure and monitor the quality of ADR management. Educational strategies may help improve the quality of ADR management processes.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference73 articles.
1. Australian Government, Department of Health, Therapeutic Goods Administration (2019) Reporting adverse events. [cited 2020 Nov 30]; Available from: https://www.tga.gov.au/reporting-adverse-events
2. Thien FCK (2006) 3. Drug hypersensitivity. Med J Aust 01 Sept 2006 185(6):333–338
3. Wolfe D, Yazdi F, Kanji S, Burry L, Beck A, Butler C et al (2018) Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: a systematic review of systematic reviews. PloS One 13(10):e0205426
4. Organization WH (2019) Medication safety curriculum guide. [cited 2020 Nov 20]; Available from: https://www.pharmacologyeducation.org/sites/default/files/WHO%20Medication%20Safety%20Curriculum%20Guide%202019.pdf
5. Organisation WH (2002) Safety of medicines – a guide to detecting and reporting adverse drug reactions – why health professionals need to take action
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献